Minimally invasive surgery in cervical cancer.

IF 1 Q2 Medicine

Minerva ginecologica Pub Date : 2020-12-11 DOI:10.23736/S0026-4784.20.04726-7

G. Bogani, V. Di Donato, V. Chiappa, Salvatore Lopez, M. Monti, L. Muzii, P. Benedetti Panici, A. Ditto, F. Raspagliesi

{"title":"Minimally invasive surgery in cervical cancer.","authors":"G. Bogani, V. Di Donato, V. Chiappa, Salvatore Lopez, M. Monti, L. Muzii, P. Benedetti Panici, A. Ditto, F. Raspagliesi","doi":"10.23736/S0026-4784.20.04726-7","DOIUrl":null,"url":null,"abstract":"In recent years, minimally invasive surgery has replaced open surgery for almost all surgical indications in gynecological practice. Recently, the results of the Laparoscopic Approach to Cervical Cancer (LACC) trial questioned the role of minimally invasive surgery for patients affected by earlystage cervical cancer. In the present paper, we discussed the current evidence regarding the adoption of minimally invasive surgery for patients with cervical cancer. We evaluated the current evidence focusing on four interesting features: (i) the impact of tumor volume; (ii) reasons explaining worse outcomes of patients undergoing minimally invasive surgery; (iii) methods to reduce the risk of recurrence during minimally invasive surgery; and (iv) the effect of minimally invasive surgery in patients with locally advanced cervical cancer. At the moment, in the light of current evidence, minimally invasive radical hysterectomy should be offered only in the context of clinical trials. Extensive counseling and appropriate patients' selection are needed. Further prospective evidence is warranted to identify the better approach for cervical cancer patients.","PeriodicalId":18745,"journal":{"name":"Minerva ginecologica","volume":" ","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2020-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva ginecologica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S0026-4784.20.04726-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

Abstract

In recent years, minimally invasive surgery has replaced open surgery for almost all surgical indications in gynecological practice. Recently, the results of the Laparoscopic Approach to Cervical Cancer (LACC) trial questioned the role of minimally invasive surgery for patients affected by earlystage cervical cancer. In the present paper, we discussed the current evidence regarding the adoption of minimally invasive surgery for patients with cervical cancer. We evaluated the current evidence focusing on four interesting features: (i) the impact of tumor volume; (ii) reasons explaining worse outcomes of patients undergoing minimally invasive surgery; (iii) methods to reduce the risk of recurrence during minimally invasive surgery; and (iv) the effect of minimally invasive surgery in patients with locally advanced cervical cancer. At the moment, in the light of current evidence, minimally invasive radical hysterectomy should be offered only in the context of clinical trials. Extensive counseling and appropriate patients' selection are needed. Further prospective evidence is warranted to identify the better approach for cervical cancer patients.

查看原文本刊更多论文

子宫颈癌的微创手术。

近年来，在妇科实践中，微创手术几乎取代了开放手术的所有手术指征。最近，腹腔镜治疗癌症宫颈癌（LACC）试验的结果对微创手术在早期癌症宫颈癌患者中的作用提出了质疑。在本文中，我们讨论了目前关于癌症患者采用微创手术的证据。我们评估了目前的证据，重点关注四个有趣的特征：（i）肿瘤体积的影响；（ii）解释接受微创手术的患者的不良结果的原因；（iii）在微创手术期间降低复发风险的方法；以及（iv）微创手术对局部晚期宫颈癌症患者的影响。目前，根据目前的证据，微创根治性子宫切除术只能在临床试验中进行。需要广泛的咨询和适当的患者选择。需要进一步的前瞻性证据来确定治疗癌症宫颈癌患者的更好方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Minerva ginecologica OBSTETRICS & GYNECOLOGY-

CiteScore

3.00

自引率

0.00%

发文量

期刊介绍： The journal Minerva Ginecologica publishes scientific papers on obstetrics and gynecology. Manuscripts may be submitted in the form of editorials, original articles, review articles, case reports, therapeutical notes, special articles and letters to the Editor. Manuscripts are expected to comply with the instructions to authors which conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Editors by the International Committee of Medical Journal Editors (www.icmje.org). Articles not conforming to international standards will not be considered for acceptance.